Clinical and Histological Analysis of Human Gingival Phenotypes

June 27, 2023 updated by: Aristotle University Of Thessaloniki

Clinical, Histological and Immunohistochemical Characterization of Human Gingival Phenotypes

The goal of this observational study is to compare the composition of the human gingiva in different gingival phenotypes. The main questions to answer are:

  • Is there any difference in the cellular composition of the gingiva between thin and thick gingival phenotype?
  • Is there any difference in the molecular composition of the gingiva between thin and thick gingival phenotype?

The participants were divided in two groups (thin and thick phenotype) and a biopsy of healthy gingiva was obtained from each one them. The biopsies were analyzed histologically and the collected data will be analyzed statistically in order to identify possible differences between the gingival phenotypes.

Study Overview

Detailed Description

Healthy volunteers were assigned in one of two groups:

  • Group 1: Thin gingiva, when the free gingiva was evaluated as transparent, after the insertion of a periodontal probe (Hu-Friedy XP-23/QW, Hu-Friedy,Chicago,IL,USA) in the middle of the facial dentogingival sulcus of a maxillary central incisor
  • Group 2: Thick gingiva: when the free gingiva was evaluated as non-transparent, using the same methodology.

A full thickness sample of the oral mucosa of each one of the participants was collected under local anaesthesia. The sample had a rectangular shape, with a length of 4 millimeters and a width of 1 millimeter. It had a vertical orientation and it was expanding at the both sides of the mucogingival junction.

The oral mucosa samples were processed for histological and immunohistochemical analysis. Staining with haematoxylin-eosin was performed in order to describe the tissue histologically and also calculate the total number of the cells it contained. Immunohistochemical staining with anti-Vimentin,anti-Cluster of Differentiation 68, anti-Ki-67 and anti-Smooth Muscle Actin antibodies was applied for the calculation of the numbers of fibroblasts, macrophages, Ki-67-positive cells and Smooth muscle actin positive cells respectively. Immunohistochemical staining was also performed in order to determine the levels of expression of Collagen I, Collagen V, Elastin and Hyaluronic acid.

Whole slide images of the specimens were acquired with the use of the NanoZoomer 2.0HT (Hamamatsu Pho-tonics K.K., Hamamatsu, Japan). Cell counting will be performed automatically using an image analysis software (QuPath 3.0). The levels of molecular expression will be assessed with the use of the same software and will be expressed as a percentage of the area of the connective tissue that is occupied by the investigated molecules.

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Macedonia
      • Thessaloniki, Macedonia, Greece, 54124
        • Aristotle University of Thessaloniki

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy volunteers referred to the Department of Preventive Dentistry, Periodontology and Implant Biology of the Dental School of the Aristotle University of Thessaloniki.

Description

Inclusion Criteria:

  • Healthy adults

Exclusion Criteria:

  • Attachment loss or Probing depths greater than 2 millimeters at the maxillary central incisors
  • Altered passive eruption of the maxillary incisors
  • Previous surgery or orthodontic treatment in the anterior maxilla
  • Medical conditions or medication affecting soft tissue metabolism
  • Tooth crowding or abnormal angulation or abrasion of the maxillary incisors
  • Restorations at the buccal surface of the maxillary central incisors
  • Smoking
  • Pregnancy or lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Thin Phenotype
Participants with transparent free gingiva of the maxillary central incisor
Histological staining of gingival biopsies with haematoxylin-eosin.
Immunohistochemical staining of gingival biopsies using anti-Vimentin, anti-Collagen I, anti-Collagen V, anti-Elastin, anti-Hyaluronic acid, anti-Smooth muscle actin, anti-Cluster of Differentiation 68 and anti-ki67 antibodies.
Thick Phenotype
Participants with non-transparent free gingiva of the maxillary central incisor
Histological staining of gingival biopsies with haematoxylin-eosin.
Immunohistochemical staining of gingival biopsies using anti-Vimentin, anti-Collagen I, anti-Collagen V, anti-Elastin, anti-Hyaluronic acid, anti-Smooth muscle actin, anti-Cluster of Differentiation 68 and anti-ki67 antibodies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cell density
Time Frame: Baseline
The number of all types of cells per square millimeter of the connective tissue
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fibroblast Density
Time Frame: Baseline
The number of fibroblasts per square millimeter of the connective tissue
Baseline
Macrophage Density
Time Frame: Baseline
The number of macrophages per square millimeter of the connective tissue
Baseline
Density of Ki-67-positive cells
Time Frame: Baseline
The number of Ki-67-positive cells per square millimeter of the connective tissue
Baseline
Density of Smooth Muscle Actin positive cells
Time Frame: Baseline
The number of Smooth Muscle Actin positive cells per square millimeter of the connective tissue
Baseline
Collagen I area ratio
Time Frame: Baseline
The percentage of the area of the connective tissue which is occupied by Collagen I
Baseline
Collagen V area ratio
Time Frame: Baseline
The percentage of the area of the connective tissue which is occupied by Collagen V
Baseline
Elastin area ratio
Time Frame: Baseline
The percentage of the area of the connective tissue which is occupied by Elastin
Baseline
Hyaluronic acid area ratio
Time Frame: Baseline
The percentage of the area of the connective tissue which is occupied by Hyaluronic acid
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Keratinized tissue width
Time Frame: Baseline
The length (millimeters) of the line that connects the mucogingival junction and the gingival margin, at the middle of the facial surface of the maxillary central incisor
Baseline
Gingival thickness
Time Frame: Baseline
The thickness (millimeters) of the gingiva, measured with an ultrasonic biometer (PIROP Biometric scanner, ECHO-SON S.A., Poland) at the middle of the line that connects the mucogingival junction and the gingival margin, at the middle of the facial surface of the maxillary central incisor
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Sotiris Kalfas, Professor, Aristotle University of Thessaloniki

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 5, 2020

Primary Completion (Actual)

December 1, 2022

Study Completion (Actual)

December 1, 2022

Study Registration Dates

First Submitted

March 22, 2023

First Submitted That Met QC Criteria

June 27, 2023

First Posted (Actual)

June 28, 2023

Study Record Updates

Last Update Posted (Actual)

June 28, 2023

Last Update Submitted That Met QC Criteria

June 27, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 1399

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Histological analysis

Subscribe